Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1821-1830 of 2867 for cancer

Edit search filters
  1. Suppression Of Ovarian Function With Either Tamoxifen Or Exemestane Compared With Tamoxifen Alone In Treating Premenopausal Women With Hormone-Responsive Breast Cancer

    Eau Claire, WI

  2. A Study Of Rucaparib In Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer (ARIEL2)

    Jacksonville, FL, Rochester, MN

  3. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment Of Liver Metastases In A Randomized, Double-blind, Placebo‑Controlled Phase-III STudy

    Rochester, MN

  4. Phase III Open Label Study Of MEDI 4736 With/Without Tremelimumab Versus Standard Of Care (SOC) In Recurrent/Metastatic Head And Neck Cancer

    Rochester, MN

  5. Study Of Safety And Efficacy Of Dapagliflozin + Metformin XR Versus Metformin XR In Participants With HR+, HER2-, Advanced Breast Cancer While On Treatment With Alpelisib And Fulvestrant

    Jacksonville, FL, Rochester, MN

  6. A Study To Evaluate The Effectiveness And Safety Of Rivaroxaban As Prophylaxis Treatment For Venous Thromboembolism (VTE) In Ambulatory Cancer Patients

    Rochester, MN

  7. TAS-102 And Radiation Therapy In Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, Or Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Alisertib And Fulvestrant In Treating Patients With Hormone Receptor Positive Breast Cancer That Is Metastatic Or Locally Advanced And Cannot Be Removed By Surgery

    Rochester, MN

  9. Transoral Surgery Followed By Low-Dose Or Standard-Dose Radiation Therapy With Or Without Chemotherapy In Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

    Scottsdale/Phoenix, AZ

  10. Cetuximab With Or Without Tivantinib In Treating Patients With Head And Neck Cancer That Is Recurrent, Metastatic, Or Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer